Engineered Cardiac Tissues Generated in the Biowire II: A Platform for Human-Based Drug Discovery

Recent advances in techniques to differentiate human induced pluripotent stem cells (hiPSCs) hold the promise of an unlimited supply of human derived cardiac cells from both healthy and disease populations. That promise has been tempered by the observation that hiPSC-derived cardiomyocytes (hiPSC-CM...

Descripción completa

Detalles Bibliográficos
Autores principales: Feric, Nicole T, Pallotta, Isabella, Singh, Rishabh, Bogdanowicz, Danielle R, Gustilo, Marietta M, Chaudhary, Khuram W, Willette, Robert N, Chendrimada, Tim P, Xu, Xiaoping, Graziano, Michael P, Aschar-Sobbi, Roozbeh
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2019
Materias:
Emerging Technologies, Methods and Models
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6813749/
https://www.ncbi.nlm.nih.gov/pubmed/31385592
http://dx.doi.org/10.1093/toxsci/kfz168

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6813749/
https://www.ncbi.nlm.nih.gov/pubmed/31385592
http://dx.doi.org/10.1093/toxsci/kfz168

Ejemplares similares